Treatment with angiotensin converting enzyme inhibitors, angiotensin-II-antagonists and beta-blockers in an unselected group of patients with chronic heart failure

被引：0
|
作者：
Ragnar Watz
Ann-Britt Ekstrand
Victoria Engelbrektson
Björn Beermann
机构：
[1] Kristinehamn’s Hospital,Department of Medicine
[2] Medical Products Agency,undefined
来源：
European Journal of Clinical Pharmacology | 2005年 / 61卷
关键词：
Heart Failure; Chronic Heart Failure; Heart Failure Patient; Carvedilol; Angiotensin Converting Enzyme Inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：209 / 214
页数：5
相关论文
共 50 条
  • [31] Cost of heart failure in patients receiving β-blockers and angiotensin-converting enzyme inhibitors
    Weintraub, WS
    Kawabata, H
    Tran, M
    L'italien, GJ
    Chen, RS
    CLINICAL DRUG INVESTIGATION, 2004, 24 (05) : 255 - 264
  • [32] Effect of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular deaths in patients with and without diabetes mellitus in advanced chronic heart failure
    Tokatli, A. Alptug
    Kozdag, G.
    Ural, D.
    Karauzum, K.
    Yilmaz, I.
    Argan, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 203 - 203
  • [33] Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis
    Hasegawa, Daisuke
    Lee, Young Im
    Prasitlumkum, Narut
    Chopra, Lakshay
    Nishida, Kazuki
    Smith, Robert L.
    Sato, Ryota
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 62 : 69 - 77
  • [34] Angiotensin-converting enzyme inhibitors, angiotensin-II receptor antagonists, beta-blockers and ivabradine as supportive therapy in pulmonary hypertension: drug safety and tolerability
    Correale, M. Michele
    Quiete, S.
    Petrucci, R.
    Ferraretti, A.
    Padovano, G.
    Zicchino, S.
    Monaco, I.
    Ieva, R.
    Brunetti, N. D.
    Di Biase, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 415 - 415
  • [35] Reasons for non-prescription of angiotensin-converting enzyme inhibitors and beta-blockers in ambulatory heart failure: the SONIC survey
    Komajda, M
    Aupetit, J
    Mosnier, M
    EUROPEAN HEART JOURNAL, 2003, 24 : 290 - 290
  • [36] Short-term results in patients with acute heart failure under treatment with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers
    Haro Bosch, A.
    Cabello Zamora, I
    Fuentes Gonzalez, L.
    Lopez Delmas, N.
    Jacob Rodriguez, J.
    Malchair, P.
    EMERGENCIAS, 2023, 35 (03): : 235 - 236
  • [37] Beta-blockers, calcium channel blockers, angiotensin converting enzyme inhibitors and angiotensin receptor blockers: should they be stopped or not before ambulatory anaesthesia?
    Smith, Ian
    Jackson, Ian
    CURRENT OPINION IN ANESTHESIOLOGY, 2010, 23 (06) : 687 - 690
  • [38] Comparison of Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers for Prognosis of Heart Failure in the Real World
    Higashi, Kensaku
    CIRCULATION, 2019, 140
  • [39] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Edoardo Bertero
    Roberta Miceli
    Alessandra Lorenzoni
    Manrico Balbi
    Giorgio Ghigliotti
    Francesco Chiarella
    Claudio Brunelli
    Francesca Viazzi
    Roberto Pontremoli
    Marco Canepa
    Pietro Ameri
    Internal and Emergency Medicine, 2019, 14 : 1083 - 1090
  • [40] Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure
    Bertero, Edoardo
    Miceli, Roberta
    Lorenzoni, Alessandra
    Balbi, Manrico
    Ghigliotti, Giorgio
    Chiarella, Francesco
    Brunelli, Claudio
    Viazzi, Francesca
    Pontremoli, Roberto
    Canepa, Marco
    Ameri, Pietro
    INTERNAL AND EMERGENCY MEDICINE, 2019, 14 (07) : 1083 - 1090
12345